Why did Trump launch a new mobile phone service?
How is Israel-Iran conflict affecting oil prices?
What impact will BOJ slowing bond taper have?
Why did popular home goods retailer file bankruptcy?
How will EU's Russian gas ban affect energy markets?
What caused WhatsApp to introduce ads now?
Why is JPMorgan entering cryptocurrency with JPMD?
AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes
news.abbvie.com/2025-06-16-AbbVie-Provides-Update-on-VERONA-Trial-for-Newly-Diagnosed-Higher-Risk-Myelodysplastic-SyndromesNORTH CHICAGO, Ill., June 16, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine in the treatment of newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) did not meet the primary endpoint of…
This story appeared on news.abbvie.com, 2025-06-17 02:33:14.997000.